SalioGen Therapeutics
Accelerating the impact of genetic medicines for patients with Gene Coding™ technology
55 employees · est. 2020 · Lexington, United States
Tango Therapeutics
Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medicines.
157 employees · est. 2017 · Boston, United States
Tango Therapeutics is the older company (2020 vs 2017).
Side-by-Side Comparison
| Metric | SalioGen Therapeutics | Tango Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2017 older |
| Headquarters | ||
| Headquarters | Lexington, United States | Boston, United States |
| Employees | ||
| Employees | 55 | 157 |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Unknown | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $135.00M | $351.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | genetic medicine development, biotechnological research, gene modification | Medicine Development, Genetically Targeted Therapies, Cancer Treatment Research, Clinical Trials, Drug Pipeline Expansion, Biotechnology Innovations |
| Target Customers | ||
| Target Customers | medical researchers, biotech firms, healthcare providers | Cancer Patients, Oncologists, Healthcare Providers, Pharmaceutical Researchers, Biopharma Investors |
| Taxonomy | ||
| Taxonomy | Genetic MedicineGene Coding TechnologyNon-Viral Gene IntegrationEDIT PlatformStargardt DiseaseCystic Fibrosis +9 | Clinical-stagePrecision MedicineCancer TreatmentTumor Suppressor TargetingSynthetic LethalityCRISPR-based Discovery +8 |
| Website | ||
| Website | saliogen.com | tangotx.com |
About SalioGen Therapeutics
SalioGen Therapeutics is a cutting-edge biotechnology firm, founded in 2020, headquartered in the United States. The company is dedicated to pioneering advancements in genetic medicine through its innovative Gene Coding™ technology. This proprietary method offers a non-viral approach to gene integra...
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company, established in 2017, focused on developing precision medicines to target cancer by exploiting tumor suppressor loss. Its mission is encapsulated in the slogan: "Targeting tumor suppressor loss to unmask vulnerabilities for the next genera...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches SalioGen Therapeutics and Tango Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when SalioGen Therapeutics or Tango Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare SalioGen Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at SalioGen Therapeutics on 28 Jan 2026, and Tango Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
